Healthy volunteer
Conditions
Interventions
Take a supplement containing 300 mg of NMN for 8 weeks.
Sponsors
Renais Crinic Nihonbashi
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: [1] Postmenopausal women aged 50 to 79 at the time of consent to participate in the study [2]Individuals who are healthy and are not received treatment of disease [3]Individuals whose written informed consent has been obtained [4]Individuals who can come to the designated examination date and receive the examination [5]Individuals judged appropriate for the study by the principal
Exclusion criteria
Exclusion criteria: [1]Individuals using medical products [2]Individuals under treatment or with history of mental disorders, sleep disorders, hypertension, diabetes, lipid metabolism abnormality, or other serious disorders [3]Individuals with history of serious diseases (hepatic, renal, cardiovascular, respiratory, hematologic, etc.) [4]Individuals with history of gastrointestinal disorders except for appendicitis [5]Individuals with skin disease symptoms such as atopic dermatitis [6]Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months [7]Individuals who have experienced mood disorder or condition deterioration due to blood sampling in the past [8]Individuals with serious anemia [9]Individuals deemed sensitive to the test product or highly allergic to foods or medical drugs [10]Individuals who excessively take alcohol (expressed in an amount of alcohol: over 60mg/day) [11]Individuals whose life style will change during the test period (ex. travel for a long time) [12]Individuals who participated in other clinical studies in the past three months [13]Individuals judged inappropriate for the study by the principal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IGF-1, DHEA-s, E2, Free testosterone, cortisol, TSH, FT3, FT4, Insulin, NMN, NAD, Sirt1 mRNA | — |
Secondary
| Measure | Time frame |
|---|---|
| Immunity judgment test,Measurement of fluorescent AGEs (AGE reader),Skin VAS questionnaire | — |
Countries
Japan
Contacts
Public ContactYuji Morita
Renais Crinic Nihonbashi Director
Outcome results
None listed